Nature’s Instincts, Inc. terminates pending merger with United Treatment Centers, Inc.

(PR NewsChannel) / December 23, 2011 / HOUSTON 

Houston-based Nature’s Instincts, Inc. announced today it has decided not to proceed with the pending acquisition and merger with United Treatment Centers, Inc. (Pinksheets: UTRM.PK – News).

Nature’s Instincts’ management has decided the merger is not in the best interest of the Company or it’s shareholders.

Richard M. Johnson, CEO of Nature’s Instincts, Inc., stated, “We have decided to pursue a different business path to advance the company’s proprietary arsenal of health and fitness products. This announcement allows both companies to continue to facilitate their individual business plans.”

About Nature’s Instincts, Inc.: Nature’s Instincts has acquired a proprietary patent-pending platform of all natural health products based on a core technology derived from stem cell research. The products are comprised of a series of natural plant extracts and other natural components with a wide array of properties, all of which benefit from their unique abilities to better integrate the product’s advantages into human cell structure and work on the body’s own stem cells. Natures Instincts, Inc. offers a total of seven products. They are Stemulite II AM for men, Stemulite II PM for men, Stemulite II AM for women, Stemulite II PM for women, ProStem II, SominaPM and AlertNRG. Nature’s Instincts’ platform of products are all-natural and have no known negative side effects and are non-addictive. For more information visit:

“Safe Harbor” Statement: Certain statements in this release are “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. Such statements are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the Company’s ability to meet the terms and conditions required to obtain its project financing, risks and delays associated with product development, risk of market acceptance of new products, risk of technology or product obsolescence, competitive risks, reliance on development partners and the need for additional capital.

Richard M. Johnson
Nature’s Instincts, Inc.

Direct link:

SOURCE:  Nature's Instincts, Inc.

This press release is distributed by PR NewsChannel. Your News. Everywhere.